Article
Effects of SPI1-mediated transcriptome remodeling on Alzheimer's disease-related phenotypes in mouse models of Aβ amyloidosis.
Nature communications - 11 May 2024
Kim Byungwook, Dabin Luke Child, Tate Mason Douglas, Karahan Hande, Sharify Ahmad Daniel, Acri Dominic J, Al-Amin Md Mamun, Philtjens Stéphanie, Smith Daniel Curtis, Wijeratne H R Sagara, Park Jung Hyun, Jucker Mathias, Kim Jungsu
Abstract excerpt
SPI1 was recently reported as a genetic risk factor for Alzheimer's disease (AD) in large-scale genome-wide association studies. However, it is unknown whether SPI1 should be downregulated or increased to have therapeutic benefits. To investigate the effect of modulating SPI1 levels on AD pathogenesis, we performed extensive biochemical, histological, and transcriptomic analyses using both Spi1-knockdown and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
